Affordable Access

deepdyve-link
Publisher Website

Indução do padrão citoplasmático em forma de “bastões e anéis” através do tratamento da hepatite C: relato de caso

Journal
Revista Brasileira de Reumatologia
Publisher
Springer (Biomed Central Ltd.)
Identifiers
DOI: 10.1016/j.rbr.2014.01.012
Keywords
Disciplines
  • Biology
  • Design
  • Medicine
License
Unknown

Abstract

Abstract Female patient, complaining of weakness and pain in hypogastric, was admitted to the emergency department of the University Hospital of the West of Paraná (HUOP). During the interview reported treatment of chronic infection with hepatitis C virus (HCV) with peginterferon and ribavirin. Among the laboratory tests ordered, the search for self‐antibodies against cellular antigens, traditionally known as antinuclear factor, showed fluorescence shaped like rods and/or rings in the cytoplasm of cells. This study attempts to clarify the relationship between this pattern not yet completely understood and the clinical picture of the patient. This pattern is characterized by 3‐10μm rods or rings with 2‐5μm in diameter scattered throughout the cytoplasm of the cell. Therefore, this new standard has been designated as “rods and rings” (RR). The antigenic target of this reaction was identified as inosine‐5’‐monophosphate dehydrogenase type 2 (IMPDH2) which is a key enzyme in the synthesis of purine nucleotides. The IMPDH2 enzyme aggregated or modified shaped RR in those patients treated with ribavirin may become antigenic and induce an autoimmune response. It is possible that interferon alpha stimulates the occurrence of anti‐RR reactivity apparently induced by ribavirin. So far it is not known why the standard RR in HEp2 cells occurs only in a fraction of patients with HCV. Previous studies presented in this paper allow affirming that these antibodies associated with the standard RR are strongly related to hepatitis C. Moreover, it can be stated that the occurrence of anti‐RR reactivity is promoted by combination therapy with interferon and ribavirin.

Report this publication

Statistics

Seen <100 times